| Literature DB >> 29801191 |
Oula Knuutinen1,2,3, Maria Kousi4,5, Maria Suo-Palosaari2,6, Jukka S Moilanen1,2,7, Hannu Tuominen8, Leena Vainionpää9, Tarja Joensuu4,10,11, Anna-Kaisa Anttonen4,10,11,12, Johanna Uusimaa1,2,3,9, Anna-Elina Lehesjoki4,10,11, Päivi Vieira1,2,9.
Abstract
Alexander disease (AxD) is a genetic leukodystrophy caused by GFAP mutations leading to astrocyte dysfunction. Neonatal AxD is a rare phenotype with onset in the first month of life. The proband, belonging to a large pedigree with dominantly inherited benign familial neonatal epilepsy (BFNE), had a phenotype distinct from the rest of the family, with hypotonia and macrocephaly in addition to drug-resistant neonatal seizures. The patient deteriorated and passed away at 6 weeks of age. The pathological and neuroimaging data were consistent with the diagnosis of AxD. Genetic analysis of the proband identified a novel de novo GFAP missense mutation and a KCNQ2 splice site mutation segregating with the BFNE phenotype in the family. The GFAP mutation was located in the coil 2B region of GFAP protein, similar to most neonatal-onset AxD cases with an early death. The clinical and neuroradiological features of the previously published neonatal AxD patients are presented. This study further supports the classification of neonatal-onset AxD as a distinct phenotype based on the age of onset. Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29801191 DOI: 10.1055/s-0038-1649500
Source DB: PubMed Journal: Neuropediatrics ISSN: 0174-304X Impact factor: 1.947